Methotrexate

Back to search

Molecule Structure

Scientific Name

Methotrexate

Description of the Drug

Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00563

Brand Name(s)

Amethopterin, Ebetrex, Emtexate high-pot, Emtexate pf, Folex, Maxtrex, Methotrexate, Metoject, Mexate, Otrexup, Otrexup pfs, Rasuvo, Reditrex, Rheumatrex, Trexall, Zlatal

Company Owner(s)

Lotus Pharmaceutical Co Ltd Nantou Plant, Bristol Myers Squibb, Otter Pharmaceuticals Llc, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Fresenius Kabi Usa Llc, Hospira Inc, Bristol Myers Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dihydrofolate reductase SINGLE PROTEIN INHIBITOR CHEMBL202

Unichem Links

SureChEMBL SCHEMBL3711
PharmGKB PA450428
Human Metabolome Database HMDB0014703
DrugBank DB00563
PubChem: Thomson Pharma 14760074 14808762
PubChem 126941
Mcule MCULE-6523054194
NMRShiftDB 80020728
LINCS LSM-5690
Nikkaji J2.334E
PDBe MTX
BindingDB 66082 18050
EPA CompTox Dashboard DTXSID4020822
DrugCentral 1751
Brenda 39751 91627 132028 49198 3613 229641 138514 241 220748 229642 9550
ChemicalBook CB2704227 CB2739302
Guide to Pharmacology 4674 4815
rxnorm REDITREX XATMEP METHOTREXATE SODIUM RASUVO METHOTREXATE OTREXUP TREXALL
PubChem: Drugs of the Future 22395177
KEGG Ligand C01937
ChEBI 44185
ZINC ZINC000001529323